CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
We are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. W...
Phase 3
Roma, Italy and 32 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Roma, Italy and 338 other locations
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...
Phase 3
Roma, Lazio, Italy and 336 other locations
Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys...
Phase 3
Roma, Lazio, Italy and 82 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Roma, Lazio, Italy and 144 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Roma, Lazio, Italy and 116 other locations
(for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.Parti...
Phase 3
Rome, Italy and 948 other locations
of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...
Phase 3
Rome, Roma, Italy and 707 other locations
AFFINITY Study is a phase 2, open-label, basket study to evaluate the efficacy and safety of atrasentan in patients with proteinuric glomerular disease...
Phase 2
Pavia, Lombardy, Italy and 39 other locations
The proposed study is designed to provide patients previously enrolled in Phase 1 and 2 studies of DCR-PHXC and their siblings (\<18 years old) long-...
Phase 3
Roma, Italy and 22 other locations
Clinical trials
Research sites
Resources
Legal